Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Comparative Observational Study In Rheumatoid Arthritis (RA) Patients Who Are Treated With A TNF Inhibitor Or Tocilizumab As The First Biologic Therapy

NCT01543503 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01543503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01543503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Comparative Observational Study In Rheumatoid Arthritis (RA) Patients Who Are Treated With A TNF Inhibitor Or Tocilizumab As The First Biologic Therapy
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
February 28, 2015
Enrollment
1,225 (actual)
Sites
154

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis